Biblio

Export 1237 results:
Author Title Type [ Year(Asc)]
Filters: First Letter Of Last Name is D  [Clear All Filters]
2017
S. Licher, de Bruijn, R. F. A. G., Wolters, F. J., M Zillikens, C., M Ikram, A., and M Ikram, K., “Vitamin D and the Risk of Dementia: The Rotterdam Study.”, J Alzheimers Dis, vol. 60, no. 3, pp. 989-997, 2017.
C. Reed, Happich, M., Argimon, J. Maria, Haro, J. Maria, Wimo, A., Bruno, G., Dodel, R., Jones, R. W., Vellas, B., and Belger, M., “What Drives Country Differences in Cost of Alzheimer's Disease? An Explanation from Resource Use in the GERAS Study.”, J Alzheimers Dis, vol. 57, no. 3, pp. 797-812, 2017.
H. Borghys, Van Broeck, B., Dhuyvetter, D., Jacobs, T., de Waepenaert, K., Erkens, T., Brooks, M., Thevarkunnel, S., and Araujo, J. A., “Young to Middle-Aged Dogs with High Amyloid-β Levels in Cerebrospinal Fluid are Impaired on Learning in Standard Cognition tests.”, J Alzheimers Dis, vol. 56, no. 2, pp. 763-774, 2017.
H. Borghys, Van Broeck, B., Dhuyvetter, D., Jacobs, T., de Waepenaert, K., Erkens, T., Brooks, M., Thevarkunnel, S., and Araujo, J. A., “Young to Middle-Aged Dogs with High Amyloid-β Levels in Cerebrospinal Fluid are Impaired on Learning in Standard Cognition tests.”, J Alzheimers Dis, vol. 56, no. 2, pp. 763-774, 2017.
2016
J. Dukart, Sambataro, F., and Bertolino, A., “Accurate Prediction of Conversion to Alzheimer's Disease using Imaging, Genetic, and Neuropsychological Biomarkers.”, J Alzheimers Dis, vol. 49, no. 4, pp. 1143-59, 2016.
A. Tramutola, Pupo, G., Di Domenico, F., Barone, E., Arena, A., Lanzillotta, C., Broekaart, D., Blarzino, C., Head, E., D Butterfield, A., and Perluigi, M., “Activation of p53 in Down Syndrome and in the Ts65Dn Mouse Brain is Associated with a Pro-Apoptotic Phenotype.”, J Alzheimers Dis, vol. 52, no. 1, pp. 359-71, 2016.
T. C. Durazzo, Korecka, M., Trojanowski, J. Q., Weiner, M. W., Hara, R. O. ', Ashford, J. W., and Shaw, L. M., “Active Cigarette Smoking in Cognitively-Normal Elders and Probable Alzheimer's Disease is Associated with Elevated Cerebrospinal Fluid Oxidative Stress Biomarkers.”, J Alzheimers Dis, vol. 54, no. 1, pp. 99-107, 2016.
E. Stogmann, Moser, D., Klug, S., Gleiss, A., Auff, E., Dal-Bianco, P., Pusswald, G., and Lehrner, J., “Activities of Daily Living and Depressive Symptoms in Patients with Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.”, J Alzheimers Dis, vol. 49, no. 4, pp. 1043-50, 2016.
T. Minh Do, Dodacki, A., Alata, W., Calon, F., Nicolic, S., Scherrmann, J. - M., Farinotti, R., and Bourasset, F., “Age-Dependent Regulation of the Blood-Brain Barrier Influx/Efflux Equilibrium of Amyloid-β Peptide in a Mouse Model of Alzheimer's Disease (3xTg-AD).”, J Alzheimers Dis, vol. 49, no. 2, pp. 287-300, 2016.
T. Minh Do, Dodacki, A., Alata, W., Calon, F., Nicolic, S., Scherrmann, J. - M., Farinotti, R., and Bourasset, F., “Age-Dependent Regulation of the Blood-Brain Barrier Influx/Efflux Equilibrium of Amyloid-β Peptide in a Mouse Model of Alzheimer's Disease (3xTg-AD).”, J Alzheimers Dis, vol. 49, no. 2, pp. 287-300, 2016.
A. Pliássova, Canas, P. M., Xavier, A. Carolina, da Silva, B. S., Cunha, R. A., and Agostinho, P., “Age-Related Changes in the Synaptic Density of Amyloid-β Protein Precursor and Secretases in the Human Cerebral Cortex.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1209-14, 2016.
M. Heffernan, Mather, K. A., Xu, J., Assareh, A. A., Kochan, N. A., Reppermund, S., Draper, B., Trollor, J. N., Sachdev, P., and Brodaty, H., “Alcohol Consumption and Incident Dementia: Evidence from the Sydney Memory and Ageing Study.”, J Alzheimers Dis, vol. 52, no. 2, pp. 529-38, 2016.
P. Joussain, Bessy, M., Fournel, A., Ferdenzi, C., Rouby, C., Delphin-Combe, F., Krolak-Salmon, P., and Bensafi, M., “Altered Affective Evaluations of Smells in Alzheimer's Disease.”, J Alzheimers Dis, vol. 49, no. 2, pp. 433-41, 2016.
M. Dlugaj, Winkler, A., Weimar, C., Dürig, J., Broecker-Preuss, M., Dragano, N., Moebus, S., Jöckel, K. - H., Erbel, R., and Eisele, L., “Anemia and Mild Cognitive Impairment in the German General Population.”, J Alzheimers Dis, vol. 49, no. 4, pp. 1031-42, 2016.
M. Dlugaj, Winkler, A., Weimar, C., Dürig, J., Broecker-Preuss, M., Dragano, N., Moebus, S., Jöckel, K. - H., Erbel, R., and Eisele, L., “Anemia and Mild Cognitive Impairment in the German General Population.”, J Alzheimers Dis, vol. 49, no. 4, pp. 1031-42, 2016.
M. Dlugaj, Winkler, A., Weimar, C., Dürig, J., Broecker-Preuss, M., Dragano, N., Moebus, S., Jöckel, K. - H., Erbel, R., and Eisele, L., “Anemia and Mild Cognitive Impairment in the German General Population.”, J Alzheimers Dis, vol. 49, no. 4, pp. 1031-42, 2016.
J. J. Gomar, Conejero-Goldberg, C., Davies, P., and Goldberg, T. E., “Anti-Correlated Cerebrospinal Fluid Biomarker Trajectories in Preclinical Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1085-97, 2016.
M. Stravalaci, Tapella, L., Beeg, M., Rossi, A., Joshi, P., Pizzi, E., Mazzanti, M., Balducci, C., Forloni, G., Biasini, E., Salmona, M., Diomede, L., Chiesa, R., and Gobbi, M., “The Anti-Prion Antibody 15B3 Detects Toxic Amyloid-β Oligomers.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1485-97, 2016.
K. Bourgade, Dupuis, G., Frost, E. H., and Fülöp, T., “Anti-Viral Properties of Amyloid-β Peptides.”, J Alzheimers Dis, vol. 54, no. 3, pp. 859-878, 2016.
E. Del Valle, Navarro, A., Martínez-Pinilla, E., Torices, S., and Tolivia, J., “Apo J and Apo D: Complementary or Antagonistic Roles in Alzheimer's Disease?”, J Alzheimers Dis, vol. 53, no. 2, pp. 639-50, 2016.
S. Vijayaraghavan, Darreh-Shori, T., Rongve, A., Berge, G., Sando, S. B., White, L. R., Auestad, B. H., Witoelar, A., Andreassen, O. A., Ulstein, I. D., and Aarsland, D., “Association of Butyrylcholinesterase-K Allele and Apolipoprotein E ɛ4 Allele with Cognitive Decline in Dementia with Lewy Bodies and Alzheimer's Disease.”, J Alzheimers Dis, vol. 50, no. 2, pp. 567-76, 2016.
E. C. Camargo, Weinstein, G., Beiser, A. S., Tan, Z. S., DeCarli, C., Kelly-Hayes, M., Kase, C., Murabito, J. M., and Seshadri, S., “Association of Physical Function with Clinical and Subclinical Brain Disease: The Framingham Offspring Study.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1597-608, 2016.
I. Karakis, Pase, M. P., Beiser, A., Booth, S. L., Jacques, P. F., Rogers, G., DeCarli, C., Vasan, R. S., Wang, T. J., Himali, J. J., Annweiler, C., and Seshadri, S., “Association of Serum Vitamin D with the Risk of Incident Dementia and Subclinical Indices of Brain Aging: The Framingham Heart Study.”, J Alzheimers Dis, vol. 51, no. 2, pp. 451-61, 2016.
C. - H. Liu, Le Bu, X. -, Wang, J., Zhang, T., Xiang, Y., Shen, L. - L., Wang, Q. - H., Deng, B., Wang, X., Zhu, C., Yao, X. - Q., Zhang, M., Zhou, H. - D., and Wang, Y. - J., “The Associations between a Capsaicin-Rich Diet and Blood Amyloid-β Levels and Cognitive Function.”, J Alzheimers Dis, vol. 52, no. 3, pp. 1081-8, 2016.
D. Bensamoun, Guignard, R., Furst, A. J., Derreumaux, A., Manera, V., Darcourt, J., Benoit, M., Robert, P. H., and David, R., “Associations between Neuropsychiatric Symptoms and Cerebral Amyloid Deposition in Cognitively Impaired Elderly People.”, J Alzheimers Dis, vol. 49, no. 2, pp. 387-98, 2016.

Pages